External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial
RecruitingNCT06655610Phase: NAStarted 2024-12-05
Summary
The investigators will assess the use of the Monarch eTNS device as a non-pharmacological treatment for patients aged 7 to 17 years with ADHD. The investigators will compare the eTNS device to a sham
Eligibility
Sex
ALL
Min Age
7 Years
Max Age
17 Years
Locations
Center for Evidence-Based Psychiatry, Psychiatric Research USlagelse, Region Sjælland, Denmark
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06655610